• News
  • SAN DIEGO
  • BioTech

Targeson receives $776,800 in year 2 of SBIR grant

San Diego's Targeson Inc. announced it has received the Notice of Award for year 2 of the company’s 2R44 grant from the National Heart, Lung, and Blood Institute of the National Institutes of Health.

To continue reading, subscribe now
or
log in to your account
User Response
0 UserComments

Targeson Inc.

Company Website

3550 General Atomics Ct. MS, 02-606
San Diego, CA 92121

Targeson Inc. Executive(s):

Joshua Rychak

  • Co-Founder
Subscribe Today!